The Science & Practice of Medical Cannabis​

This year we have decided to rename this meeting, previously called “Clinical Trials in Cannabis”, to better reflect the expanding scope of the discussions we observed during past conferences. This also denotes the fact that we place an equal emphasis on high quality cutting edge science and on translational aspects of cannabis research relating to new and established clinical applications. This is reflected in the conference program as well as in the varied backgrounds and interests of our participants.

Accordingly, CT-Cann2024 will again bring together leading researchers, clinicians, industry professionals and other related experts from around the globe to discuss ways of improving current research strategies, present new data and discoveries, and explore practical dilemmas and future avenues in this rapidly evolving field. We will emphasize practical implications for patients, researchers, prescribing clinicians and industry leaders.

CT-Cann2024 will thus inform participants of the latest evidence and concepts regarding cannabinoid therapy, aid prescribers to practically implement best practices based on the clinical implications of current research and expert opinions, serve as a platform for an exchange of ideas and practices in cannabinoid medicine, and help promote innovative and engaging discussions. As before, it will undoubtedly spark many fascinating and lively debates.

We look forward to welcoming you once again at CT-Cann2024 in the vibrant and wonderful city of London.

Sincerely,